Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a study suggests. Similar studies have shown that ...
Technological Advancements in ALS ManagementHealthcare experts highlight revolutionary technological developments in ALS careAmyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that is ...
A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.
Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...
Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...
Financial writer discusses Coya Therapeutics, Inc.'s Treg therapies for neurodegenerative diseases like ALS, FTD, and PD.
LEXINGTON, Mass. - Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology firm focused on neurogenetic medicines with a market capitalization of $290 million, announced today it is reassessing its ...
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a ...
Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...
InFlectis BioScience SAS, a drug discovery company pioneering development of therapeutics harnessing the Integrated Stress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback